Aberdeen Group
EVLO

Aberdeen Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Aberdeen Group’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,123
Closed -$716K – 961
2022
Q2 		$716K Buy
+17,123
New +$716K ﹤0.01% 821